Showing Results for
- Academic Journals (453)
Search Results
- 453
Academic Journals
- 453
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 2)The FDA has approved an sNDA for Eliquis (apixaban; Bristol-Myers Squibb and Pfizer) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or...
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 2)Companies: Bristol-Myers Squibb/AstraZeneca | Rx Pharmacologic class: Recombinant human leptin analog. Active ingredient: Metreleptin 11.3mg; per vial; lyophilized powder for SC injection after reconstitution (with...
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 3)The drug information departments of companies whose products appear in this reference may be reached by calling the numbers listed. AR Scientific (877) 960-2400 AbbVie (800) 633-9110 Abbott Laboratories (847)...
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 3)PRESCRIBING NOTES For more information on the management of HIV infection, see Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents--March 27, 2012 at www.aidsinfo.nih.gov....
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 4)Bristol-Myers Squibb and Pfizer announced that the FDA has approved Eliquis (apixaban) for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the reduction in the risk of recurrent DVT and...
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 4)PRESCRIBING NOTES For more information on the management of HIV infection, see Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents--March 27, 2012 at www.aidsinfo.nih.gov. >...
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 4)AR Scientific (877) 960-2400 AbbVie (800) 633-9110 Abbott Laboratories (847) 937-6100 Acorda Therapeutics (800) 367-5109; (914) 347-4300 Actavis (800) 432-8534; (732) 465-3600 Aegerion Pharmaceuticals...
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 1)The FDA has approved Farxiga (dapagliflozin; Bristol-Myers Squibb and AstraZeneca) tablets to improve glycemic control, with diet and exercise, in adult patients with type 2 diabetes. Dapagliflozin is a selective and...
-
From:MPR - Physician Assistants' Edition (Vol. 23, Issue 2)The FDA has approved Daklinza (daclatasvir; Bristol-Myers Squibb) for use in combination with sofosbuvir with or without ribavirin, for the treatment of chronic hepatitis C genotypes 1 and 3. The label now includes data...
-
From:MPR - Physician Assistants' Edition (Vol. 20, Issue 3)PRESCRIBING NOTES For more information on the management of HIV infection, see Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents--March 27, 2012 at www.aidsinfo.nih.gov....
-
From:MPR - Physician Assistants' Edition (Vol. 23, Issue 1)PRESCRIBING NOTES For more information on the management of HIV infection, see Guidelines for the Use of Antiretroviral Agents in HIV-1-lnfected Adults and Adolescents-March 27, 2012 atwww.aidsinfo.nih.gov....
-
From:MPR - Physician Assistants' Edition (Vol. 22, Issue 2)PRESCRIBING NOTES For more information on the management of HIV infection, see Guidelines for the Use of AntiretroviralAgents in HIV-1-InfeotedAdults and Adolescents--March 27, 2012 at www.aidsinfo.nih.gov....
-
From:MPR - Physician Assistants' Edition (Vol. 22, Issue 1)AbbVie (800) 633-9110 Abbott Laboratories (847) 937-6100 Acorda Therapeutics (800) 367-5109; (914) 347-4300 Actavis (800) 432-8534; (732) 465-3600 Aegerion Pharmaceuticals (855) 305-2347 Afaxys...
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 2)PRESCRIBING NOTES For more information on the management of HIV infection, see Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents--March 27, 2012 at www.aidsinfo.nih.gov....
-
From:MPR - Physician Assistants' Edition (Vol. 22, Issue 4)AbbVie (800) 633-9110 Actavis (800) 432-8534 (732) 465-3600 Aegerion Pharmaceuticals (855) 305-2347 Afaxys Pharmaceuticals (855) 888-2467 Akorn, Inc. (800) 535-7155 (888) 519-8384 Akrimax...
-
From:MPR - Physician Assistants' Edition (Vol. 22, Issue 4)PRESCRIBING NOTES For more information on the management of HIV infection, see Guidelines for the Use of Antiretroviral Agents in HIV-1-lnfected Adults and Adolescents--March 27, 2012 at www.aidsinfo.nih.gov....
-
From:MPR - Physician Assistants' Edition (Vol. 22, Issue 1)PRESCRIBING NOTES For more information on the management of HIV infection, see Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents-March 27, 2012 at www.aidsinfo.nih.gov....
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 2)AR Scientific (877) 960-2400 AbbVie (800) 633-9110 Acorda Therapeutics (800) 367-5109; (914) 347-4300 Actavis (800) 432-8534; (732) 465-3600 Actient Pharmaceuticals (847) 607-8890 Aegerion...
-
From:MPR - Physician Assistants' Edition (Vol. 21, Issue 2)Companies: Bristol-Myers Squibb/AstraZeneca | Rx Pharmacologic class: Sodium-glucose co-transporter 2 (SGLT2) inhibitor. Active ingredient: Dapagliflozin 5mg, lOmg; tablets. Indication: Adjunct to diet and exercise...
-
From:MPR - Physician Assistants' Edition (Vol. 22, Issue 3)Company : Bristol-Myers Squibb | Rx Pharmacologic class: HIV-1 protease inhibitor + CYP3A inhibitor Active ingredients: Atazanavir 300mg, cobici stat 150mg; tablets. Indication: HIV-1 infection in combination with...